tiprankstipranks
Marinus Pharmaceuticals price target lowered to $4 from $13 at Cantor Fitzgerald
PremiumThe FlyMarinus Pharmaceuticals price target lowered to $4 from $13 at Cantor Fitzgerald
28d ago
Marinus Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Marinus Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
28d ago
Marinus Pharmaceuticals downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Marinus Pharmaceuticals downgraded to Hold from Buy at TD Cowen
28d ago
Marinus downgraded to Market Perform from Outperform at JMP Securities
PremiumThe FlyMarinus downgraded to Market Perform from Outperform at JMP Securities
28d ago
Marinus Pharmaceuticals downgraded to Hold from Buy at Truist
Premium
The Fly
Marinus Pharmaceuticals downgraded to Hold from Buy at Truist
29d ago
Marinus notes TrustTSC trial misses primary endpoint, to evaluate alternatives
Premium
The Fly
Marinus notes TrustTSC trial misses primary endpoint, to evaluate alternatives
29d ago
Marinus Pharmaceuticals provides Ztalmy program update at investor day
PremiumThe FlyMarinus Pharmaceuticals provides Ztalmy program update at investor day
2M ago
Truist healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Truist healthcare analyst holds an analyst/industry conference call
3M ago
Ladenburg downgrades Marinus on balance sheet concerns
Premium
The Fly
Ladenburg downgrades Marinus on balance sheet concerns
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100